Education
About Us
Working with TipRanks
Follow Us
GenSight Biologics SA (DE:G49N)
FRANKFURT:G49N
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | € 2.63M | € 1.27M | € 2.58M | € 5.28M | € 4.39M |
| Gross Profit | € 2.63M | € 3.00M | € 2.58M | € 5.28M | € 4.39M |
| Operating Income | € -15.81M | € -29.70M | € -27.84M | € -28.13M | € -24.93M |
| EBITDA | € -14.76M | € -21.73M | € -26.44M | € -26.83M | € -34.13M |
| Net Income | € -14.00M | € -26.22M | € -27.62M | € -28.62M | € -34.02M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | € 2.46M | € 2.13M | € 10.61M | € 44.29M | € 37.94M |
| Total Assets | € 10.76M | € 9.13M | € 25.94M | € 56.65M | € 47.36M |
| Total Debt | € 19.11M | € 18.43M | € 12.65M | € 12.57M | € 14.45M |
| Net Debt | € 16.65M | € 16.29M | € 2.04M | € -31.72M | € -23.49M |
| Total Liabilities | € 37.68M | € 39.83M | € 41.22M | € 40.66M | € 35.69M |
| Stockholders' Equity | € -26.92M | € -30.67M | € -15.28M | € 15.99M | € 11.67M |
| Cash Flow | |||||
| Free Cash Flow | € -12.94M | € -24.67M | € -34.01M | € -17.17M | € -15.05M |
| Operating Cash Flow | € -12.94M | € -24.66M | € -33.75M | € -17.14M | € -15.04M |
| Investing Cash Flow | € 17.00K | € 209.00K | € 172.00K | € -16.00K | € -376.00K |
| Financing Cash Flow | € 13.54M | € 15.86M | € 95.00K | € 23.74M | € 33.86M |
GenSight Biologics SA Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.